223 related articles for article (PubMed ID: 26515338)
1. Secretome of human bone marrow mesenchymal stem cells: an emerging player in lung cancer progression and mechanisms of translation initiation.
Attar-Schneider O; Zismanov V; Drucker L; Gottfried M
Tumour Biol; 2016 Apr; 37(4):4755-65. PubMed ID: 26515338
[TBL] [Abstract][Full Text] [Related]
2. Niche origin of mesenchymal stem cells derived microvesicles determines opposing effects on NSCLC: Primary versus metastatic.
Attar-Schneider O; Dabbah M; Drucker L; Gottfried M
Cell Signal; 2020 Jan; 65():109456. PubMed ID: 31672605
[TBL] [Abstract][Full Text] [Related]
3. The effect of mesenchymal stem cells' secretome on lung cancer progression is contingent on their origin: primary or metastatic niche.
Attar-Schneider O; Drucker L; Gottfried M
Lab Invest; 2018 Dec; 98(12):1549-1561. PubMed ID: 30089856
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cells secretomes' affect multiple myeloma translation initiation.
Marcus H; Attar-Schneider O; Dabbah M; Zismanov V; Tartakover-Matalon S; Lishner M; Drucker L
Cell Signal; 2016 Jun; 28(6):620-30. PubMed ID: 26976208
[TBL] [Abstract][Full Text] [Related]
5. Multiple myeloma and bone marrow mesenchymal stem cells' crosstalk: Effect on translation initiation.
Attar-Schneider O; Zismanov V; Dabbah M; Tartakover-Matalon S; Drucker L; Lishner M
Mol Carcinog; 2016 Sep; 55(9):1343-54. PubMed ID: 26293751
[TBL] [Abstract][Full Text] [Related]
6. Multiple myeloma cells promote migration of bone marrow mesenchymal stem cells by altering their translation initiation.
Dabbah M; Attar-Schneider O; Zismanov V; Tartakover Matalon S; Lishner M; Drucker L
J Leukoc Biol; 2016 Oct; 100(4):761-770. PubMed ID: 27272311
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect and molecular mechanism of mesenchymal stem cells on NSCLC cells.
Pan M; Hou L; Zhang J; Zhao D; Hua J; Wang Z; He J; Jiang H; Hu H; Zhang L
Mol Cell Biochem; 2018 Apr; 441(1-2):63-76. PubMed ID: 28887716
[TBL] [Abstract][Full Text] [Related]
8. Migration and epithelial-to-mesenchymal transition of lung cancer can be targeted via translation initiation factors eIF4E and eIF4GI.
Attar-Schneider O; Drucker L; Gottfried M
Lab Invest; 2016 Sep; 96(9):1004-15. PubMed ID: 27501049
[TBL] [Abstract][Full Text] [Related]
9. BM-MSCs-derived ECM modifies multiple myeloma phenotype and drug response in a source-dependent manner.
Ibraheem A; Attar-Schneider O; Dabbah M; Dolberg Jarchowsky O; Tartakover Matalon S; Lishner M; Drucker L
Transl Res; 2019 May; 207():83-95. PubMed ID: 30738861
[TBL] [Abstract][Full Text] [Related]
10. Modulation of bone marrow mesenchymal stem cell secretome by ECM-like hydrogels.
Silva NA; Moreira J; Ribeiro-Samy S; Gomes ED; Tam RY; Shoichet MS; Reis RL; Sousa N; Salgado AJ
Biochimie; 2013 Dec; 95(12):2314-9. PubMed ID: 23994751
[TBL] [Abstract][Full Text] [Related]
11. Ribosomal proteins as distinct "passengers" of microvesicles: new semantics in myeloma and mesenchymal stem cells' communication.
Dabbah M; Lishner M; Jarchowsky-Dolberg O; Tartakover-Matalon S; Brin YS; Pasmanik-Chor M; Neumann A; Drucker L
Transl Res; 2021 Oct; 236():117-132. PubMed ID: 33887527
[TBL] [Abstract][Full Text] [Related]
12. Microvesicles derived from normal and multiple myeloma bone marrow mesenchymal stem cells differentially modulate myeloma cells' phenotype and translation initiation.
Dabbah M; Attar-Schneider O; Tartakover Matalon S; Shefler I; Jarchwsky Dolberg O; Lishner M; Drucker L
Carcinogenesis; 2017 Jul; 38(7):708-716. PubMed ID: 28838065
[TBL] [Abstract][Full Text] [Related]
13. Impact of mesenchymal stem cells' secretome on glioblastoma pathophysiology.
Vieira de Castro J; Gomes ED; Granja S; Anjo SI; Baltazar F; Manadas B; Salgado AJ; Costa BM
J Transl Med; 2017 Oct; 15(1):200. PubMed ID: 28969635
[TBL] [Abstract][Full Text] [Related]
14. eIF4E and eIF4GI have distinct and differential imprints on multiple myeloma's proteome and signaling.
Attar-Schneider O; Pasmanik-Chor M; Tartakover-Matalon S; Drucker L; Lishner M
Oncotarget; 2015 Feb; 6(6):4315-29. PubMed ID: 25717031
[TBL] [Abstract][Full Text] [Related]
15. Functional role of eukaryotic translation initiation factor 4 gamma 1 (EIF4G1) in NSCLC.
Cao Y; Wei M; Li B; Liu Y; Lu Y; Tang Z; Lu T; Yin Y; Qin Z; Xu Z
Oncotarget; 2016 Apr; 7(17):24242-51. PubMed ID: 27003362
[TBL] [Abstract][Full Text] [Related]
16. [Investigational Study of Mesenchymal Stem Cells on Lung Cancer Cell Proliferation and Invasion].
Li M; Wu Y; Liu R; Guo L; Xu T; Chen J; Xu S
Zhongguo Fei Ai Za Zhi; 2015 Nov; 18(11):674-9. PubMed ID: 26582222
[TBL] [Abstract][Full Text] [Related]
17. A novel antagonist of CXCR4 prevents bone marrow-derived mesenchymal stem cell-mediated osteosarcoma and hepatocellular carcinoma cell migration and invasion.
Fontanella R; Pelagalli A; Nardelli A; D'Alterio C; Ieranò C; Cerchia L; Lucarelli E; Scala S; Zannetti A
Cancer Lett; 2016 Jan; 370(1):100-7. PubMed ID: 26517945
[TBL] [Abstract][Full Text] [Related]
18. Infiltrating bone marrow mesenchymal stem cells increase prostate cancer stem cell population and metastatic ability via secreting cytokines to suppress androgen receptor signaling.
Luo J; Ok Lee S; Liang L; Huang CK; Li L; Wen S; Chang C
Oncogene; 2014 May; 33(21):2768-78. PubMed ID: 23792449
[TBL] [Abstract][Full Text] [Related]
19. Quantitative Secretomic Analysis Identifies Extracellular Protein Factors That Modulate the Metastatic Phenotype of Non-Small Cell Lung Cancer.
Hu R; Huffman KE; Chu M; Zhang Y; Minna JD; Yu Y
J Proteome Res; 2016 Feb; 15(2):477-86. PubMed ID: 26736068
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stem cells in non-small cell lung cancer--different from others? Insights from comparative molecular and functional analyses.
Gottschling S; Granzow M; Kuner R; Jauch A; Herpel E; Xu EC; Muley T; Schnabel PA; Herth FJ; Meister M
Lung Cancer; 2013 Apr; 80(1):19-29. PubMed ID: 23294501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
